Antibody Spike Months After Ebola Infection Surprisingly Common
Antibody Spike Months After Ebola Infection Surprisingly Common
A study of people in Sierra Leone suggests that the virus can lie in hiding from the immune system before re-emerging later and sparking a new response—although researchers didn’t examine whether this could make people infectious again.
Antibody Spike Months After Ebola Infection Surprisingly Common
Antibody Spike Months After Ebola Infection Surprisingly Common

A study of people in Sierra Leone suggests that the virus can lie in hiding from the immune system before re-emerging later and sparking a new response—although researchers didn’t examine whether this could make people infectious again.

A study of people in Sierra Leone suggests that the virus can lie in hiding from the immune system before re-emerging later and sparking a new response—although researchers didn’t examine whether this could make people infectious again.

immune response
Identifying PrognosticBiomarkers in COVID-19<br>
Identifying PrognosticBiomarkers in COVID-19
The Scientist Creative Services Team | Dec 21, 2020
Single-cell proteomics provides novel insights to COVID-19 disease progression
Beyond Acute Respiration: SARS-CoV-2&#39;s Effects on Long-Term Physiology
Beyond Acute Respiration: SARS-CoV-2's Effects on Long-Term Physiology
The Scientist Creative Services Team | Nov 11, 2020
John Connolly and Masataka Nishiga discuss the effects of SARS-CoV-2 on the neurological and cardiovascular systems.
Infographic: How Vaccines Train Innate Immunity
Infographic: How Vaccines Train Innate Immunity
Shawna Williams | Nov 1, 2020
A recent study elucidates some of the changes that occur in the body after inoculation with a tuberculosis vaccine.
First Responders: SARS-CoV-2 and the Immune System
First Responders: SARS-CoV-2 and the Immune System
The Scientist Creative Services Team | Oct 29, 2020
Angela Rasmussen and Ya-Chi Ho explore the positive and negative aspects of the host immune response to SARS-CoV-2 infection and discuss how this knowledge influences therapeutic benefits.
Rapid Characterization of the SARS-CoV-2 Immune Response Using the Simple Western Multi-Antigen Serology Assay
Rapid Characterization of the SARS-CoV-2 Immune Response Using the Simple Western Multi-Antigen Serology Assay
The Scientist Creative Services Team | Oct 21, 2020
The Simple Western automated western blotting platform accelerates characterization of the human IgG immune response to COVID-19.
Steroid Drugs Are an Effective Treatment for Severe COVID-19: WHO
Steroid Drugs Are an Effective Treatment for Severe COVID-19: WHO
Catherine Offord | Sep 3, 2020
A meta-analysis of seven randomized controlled trials concludes that dexamethasone and other corticosteroids reduce 28-day mortality in seriously ill patients.
Blood Replacement Rescues Mice from Stroke Damage
Blood Replacement Rescues Mice from Stroke Damage
Amanda Heidt | Aug 31, 2020
When mice that had suffered a stroke were given blood from a healthy donor, they experienced less tissue and neurological damage.
Immune Biomarkers Tied to Severe COVID-19: Study
Immune Biomarkers Tied to Severe COVID-19: Study
Ruth Williams | Aug 19, 2020
Increases in the levels of three cytokines are among the features linked to poor outcomes.
Studies Report Rapid Loss of COVID-19 Antibodies
Studies Report Rapid Loss of COVID-19 Antibodies
Amanda Heidt | Jun 19, 2020
The results, while preliminary, suggest that survivors of SARS-CoV-2 infection may be susceptible to reinfection within weeks or months.